Gene · 23314
Papers3,094
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,094
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-wide association study of cocaine self-administration behavior in Heterogeneous Stock rats. | Nat Commun | 2026 | 42277005 | PubTator, text mining | PubMed |
| Temporal transcriptomic profiling identifies core regulators in cytokine-induced gut barrier disruption in differentiated Caco-2 cells. | Inflamm Res | 2026 | 42257857 | PubTator, text mining | PubMed |
| Primary osteogenic sarcoma of the sternum with intravascular invasion and rapid progression: a rare case report. | Ann Med Surg (Lond) | 2026 | 42254154 | PubTator, text mining | PubMed |
| Integrative single-cell and spatial transcriptomics analysis reveals a baicalein-responsive 10-gene signature for non-small cell lung cancer. | Transl Oncol | 2026 | 42251782 | PubTator, text mining | PubMed |
| Toileting dysfunction in SATB2-associated syndrome: results from a caregiver survey. | J Pediatr Urol | 2026 | 42225445 | PubTator, text mining | PubMed |
| Clinicopathological Features and Immunohistochemical Characterization of Fourteen Cases of Gnathic Osteosarcoma. | Indian J Surg Oncol | 2026 | 42221243 | PubTator, text mining | PubMed |
| Phosphaturic mesenchymal tumor in the temporalis muscle causing tumor-induced osteomalacia: a case report and literature review. | Front Med (Lausanne) | 2026 | 42221104 | PubTator, text mining | PubMed |
| Hereditary PCOS and the environmental toxicant F-53B converge on lipid metabolic reprogramming to impair fetal brain development. | Ecotoxicol Environ Saf | 2026 | 42208382 | PubTator, text mining | PubMed |
| Astragaloside IV inhibits nasopharyngeal carcinoma progression by inhibiting SATB2/Wnt/PD-L1 pathway and enhancing the killing activity of T cells. | Eur J Histochem | 2026 | 42206678 | PubTator, text mining | PubMed |
| Understanding Aggression in SATB2-Associated Syndrome: A Mixed-Methods Study Exploring Caregiver Perspectives. | J Appl Res Intellect Disabil | 2026 | 42171333 | PubTator, text mining | PubMed |
| Clinical and imaging characteristics of phosphaturic mesenchymal tumors: a case series analysis. | BMC Cancer | 2026 | 42098680 | PubTator, text mining | PubMed |
| MLH1 promoter methylation, mismatch repair and intestinal differentiation markers in papillary thyroid carcinoma: real-world evidence from Galicia (Northwest Spain). | Virchows Arch | 2026 | 42096088 | PubTator, text mining | PubMed |
| Signet-ring cell carcinoma of the appendix presenting as diffuse uterine involvement: a case report and literature review. | Front Oncol | 2026 | 42088223 | PubTator, text mining | PubMed |
| Unmasking the Rare: Diagnostic Challenges in Sellar Chondromyxoid Fibroma and Cervical Spine Chondrosarcoma-Two Unusual Head and Neck Cases. | Neurol India | 2026 | 42087642 | PubTator, text mining | PubMed |
| High Ki-67 as an independent prognostic factor in extraskeletal osteosarcoma: a comparative cohort study. | BMC Cancer | 2026 | 42082943 | PubTator, text mining | PubMed |
| Retraction: miR-211 suppresses hepatocellular carcinoma by downregulating SATB2. | Oncotarget | 2026 | 42030541 | PubTator, text mining | PubMed |
| Giant primary hepatic osteosarcoma: A rare case report and review of the literature. | Hell J Nucl Med | 2026 | 42001442 | PubTator, text mining | PubMed |
| Diagnostic and Clinical Significance of the Special AT-Rich Sequence-Binding Protein 2 Deregulation in Gastrointestinal Malignancies. | Maedica (Bucur) | 2026 | 41978839 | PubTator, text mining | PubMed |
| [Progress in regulating stem cell functions for repair and regeneration of craniomaxillofacial tissues]. | Beijing Da Xue Xue Bao Yi Xue Ban | 2026 | 41978397 | PubTator, text mining | PubMed |
| Low-grade osteosarcoma after radiotherapy for breast cancer: a case report and literature review. | Front Oncol | 2026 | 41939465 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23314/papers?page=3